Research Article
Measurement of Inhaled Corticosteroid Adherence in Inner-City, Minority Children with Persistent Asthma by Parental Report and Integrated Dose Counter
Table 1
Sociodemographic characteristics of children ().
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Data in table have been obtained by parental self-report unless noted otherwise. aHispanic is asked as ethnicity rather than race question as per United States Census Bureau criteria [19]. bAsthma control was assessed as per National Asthma Education and Prevention Program Expert Panel Report 3: Guidelines for the Diagnosis and management of Asthma [14]. Well-controlled asthma: Symptoms ≤ 2 days/week; nighttime awakenings ≤1x/month; interference with normal activity—None; short-acting beta2-agonist use for symptom control ≤ 2 days/week; exacerbations requiring oral systemic corticosteroids 0-1/year. Not-well controlled asthma: Symptoms >2 days/week; nighttime awakenings >1x/month; Interference with normal activity—Some limitation; short-acting beta2-agonist use for symptom control >2 days/week; exacerbations requiring oral systemic corticosteroids 2-3/year. Very poorly controlled asthma: Symptoms—throughout the day; nighttime awakenings >1x/week; interference with normal activity—extremely limited; short-acting beta2-agonist use for symptom control—several times per day; exacerbations requiring oral systemic corticosteroids >3/year. cData obtained by medical record review. |